“sr-one” Archives

in
Entry Author Date Location
Second Genome Replaces DiLaura as CEO, Brings Series B to $51M 07/13/16 San Francisco
Morphic Therapeutic Garners $51,500,000 Series A Funding 06/30/16 Boston
Five Takeaways from “What’s Hot in Boston Biotech” 04/11/16 Boston
Startups Begin to Emerge From NYU’s “Virtual” Biotech Factory 03/17/16 New York
Viehbacher, Sharp & More at What’s Hot in Boston Biotech on April 6 02/18/16 Boston
Spero Eyes First Trial, Gets $30M More to Battle Drug-Resistant Bugs 02/02/16 Boston
Spero Therapeutics Receives $30,000,000 New Funding 02/02/16 Boston
CRISPR: The Path to Clinical Trials 01/29/16 Boston
Navitor Pharmaceuticals Secures $33,000,000 Series B Financing 12/18/15 Boston
London Notebook: Conversations Inside The Biomedical Golden Triangle 12/15/15 National
Constellation Pharmaceuticals Lands $55,000,000 New Funding Round 12/10/15 Boston
True North Therapeutics Secures $40,000,000 Series C Financing Round 12/03/15 San Francisco
Genocea Ditches Pneumococcus Vaccine After Phase 2 Flop, Shares Fall 10/19/15 Boston
East Coast Biotech Roundup: Zafgen, Decibel, Voyager & More 10/16/15 Boston
Decibel Therapeutics Secures $52,000,000 Series A Financing Round 10/16/15 Boston
Third Rock, SR One Put $52M Into Decibel to Battle Hearing Loss 10/15/15 Boston
RaNA CEO Renaud Turns To A Former Backer To Lead $55M Series B 07/23/15 Boston
RaNA Therapeutics Receives $55,000,000 Series B Funding Round 07/23/15 Boston
Corporate VCs Still Out to Prove They Belong At the Deal Table 06/30/15 New York
With $30M, Spero Broadens Fight Against Drug-Resistant Bugs 06/08/15 Boston
East Coast Biotech Roundup: Celgene, Blueprint(s), Intarcia & More 05/01/15 Boston
East Coast Biotech Roundup: NY Bio Fund, Sarepta, ZappRx, & More 04/03/15 Boston
ZappRx Nabs $5.6M, Inks Zafgen Deal to E-Prescribe Obesity Meds 04/02/15 Boston
With $43M, Nimbus Sheds “Discovery” Tag, Heads to First Clinical Test 03/18/15 Boston
After Unlikely Idenix Sale, Renaud Jumps to RaNA to Outfox Junk DNA 12/01/14 Boston
Pharmas, Others Bet $33M More on Aileron’s P53 Peptide Drug 10/29/14 Boston
Pappas, Chiesi Venture Fund Joins Ranks of Pharma & VC Partnerships 09/10/14 Raleigh Durham
East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More 06/20/14 Boston
Boston VC Firms, Pharmas Team up on $23.5M Series A For Navitor 06/19/14 Boston
With $22M, True North Points Toward Rare-Disease Clinical Trials 06/17/14 San Francisco
Page 1 of 5 next page »